Tokuyama

Investors

Financial Results
for Q3 FY2025
Date : Jan 30, 2026
Click to View

To Investors

Latest IR Reports
Financial Results for Q3 FY2025

Investor News

Jan 30, 2026: Tokuyama Corporation Releases Q3 FY2025 Results

Jan 30, 2026: Notice concerning Revision of Performance Forecast for Fiscal 2025

Jan 23, 2026: Notice concerning Changes of Representative Directors

Oct 29, 2025: Tokuyama Corporation Releases Q2 FY2025 Results

Oct 01, 2025: Notice regarding Completion of Closing Procedures for the "Acquisition of a Newly Established Company that will succeed JSR's in vitro diagnostic pharmaceutical business"